Solution
Software Architecture for Pharmaceutical Companies
Design software systems that meet the validation, traceability, and compliance demands of pharmaceutical development and commercialization.
Pharmaceutical software must operate in one of the most regulated environments in technology. Adapter designs architectures that satisfy FDA validation requirements, support complex drug lifecycle workflows, and enable the speed of innovation that competitive pharma demands.
Key Challenges
- 21 CFR Part 11 Validation Requirements
- ALCOA+ Data Integrity Standards
- Complex Cross-System Integration
Overview
Software Architecture for Pharmaceutical Companies
Software architecture for pharmaceutical companies requires balancing two competing forces: the need for rigorous validation, traceability, and compliance with FDA regulations, and the need for agility in an industry where speed to market directly impacts patient outcomes and revenue. Many pharma organizations swing too far in one direction, either building systems that are perfectly validated but impossibly slow to change, or deploying fast-moving tools that cannot withstand regulatory scrutiny.
Adapter designs architectures that resolve this tension. For GxP systems (those that directly support Good Manufacturing Practice, Good Laboratory Practice, or Good Clinical Practice activities), we design with 21 CFR Part 11 requirements embedded from the start: electronic signatures with meaning and intent, comprehensive audit trails that capture who changed what and when, access controls that enforce separation of duties, and data integrity controls that ensure ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate) are maintained. For non-GxP but regulated systems (commercial analytics, medical information, adverse event management), we design appropriate levels of validation that meet regulatory expectations without imposing unnecessary overhead.
Our architectures also address the unique integration landscape of pharmaceutical companies. Clinical systems must connect with EDC platforms, CTMS tools, safety databases, and regulatory submission systems. Manufacturing systems must integrate with LIMS, ERP, and quality management platforms. Commercial systems must connect with CRM, data warehouses, and third-party prescription data providers. We design integration architectures that handle these connections with proper validation, error handling, and audit trail continuity. The result is a software foundation that enables pharmaceutical innovation while maintaining the compliance posture that protects both patients and the business.
What we deliver
Solutions
- 01
Compliance-by-Architecture Design
- 02
Data Integrity Architecture Patterns
- 03
Validated Integration Framework
- 04
Risk-Based Validation Architecture
Industry Challenges
Problems we solve
21 CFR Part 11 Validation Requirements
Software systems that generate, manage, or store GxP-relevant electronic records must meet FDA validation requirements including audit trails, electronic signatures, and access controls.
ALCOA+ Data Integrity Standards
Pharmaceutical data must be Attributable, Legible, Contemporaneous, Original, and Accurate, with system architectures designed to prevent data integrity violations.
Complex Cross-System Integration
Pharma organizations use dozens of specialized systems across clinical, manufacturing, quality, regulatory, and commercial functions that must exchange data reliably.
Balancing Validation with Development Speed
Traditional pharma validation approaches can make software development painfully slow, creating pressure to find architectures that enable both compliance and agility.
What We Build
Our approach
Compliance-by-Architecture Design
We embed 21 CFR Part 11 requirements into the system architecture itself, building audit trails, electronic signatures, and access controls as core infrastructure rather than bolted-on features.
Data Integrity Architecture Patterns
Our designs use immutable event logs, versioned data stores, and change-capture mechanisms that maintain ALCOA+ compliance by making data integrity violations architecturally difficult.
Validated Integration Framework
We design integration architectures with proper validation documentation, error handling, reconciliation, and audit continuity across system boundaries.
Risk-Based Validation Architecture
We apply GAMP 5 risk-based approaches to determine the appropriate level of validation for each system component, enabling agile development for lower-risk areas while maintaining rigor where it matters.
Results
What you can expect
Zero FDA 483 observations related to software systems
Compliance-by-architecture designs pass FDA inspection without the observations that result from retroactively adding validation to existing systems.
40% faster validation lifecycle
Risk-based validation approaches and pre-validated architectural components reduce the time from development to production deployment for regulated systems.
Seamless integration across 8+ enterprise systems
Validated integration frameworks connect clinical, manufacturing, quality, and commercial systems with proper audit continuity and error handling.
FAQ
Common questions
Things clients typically ask about software design in this industry.
Ready to get started?
Tell us about your project and we will scope an engagement that fits.